CONTEXT: Inhaled corticosteroids (ICS) are associated with an increased risk of pneumonia in adult patients with chronic obstructive pulmonary disease.
Username
of pneumonia in patients taking ICS (risk ratio [RR] : 0.65; 95% confidence interval [CI] : 0.44 to 0.94). Using risk difference as effect measure, the meta-analysis including all 31 trials revealed no significant difference in the risk of pneumonia between the ICS and placebo groups (risk difference: -0.1%; 95% CI: -0.3% to 0.2%). No significant association was found between ICS and risk of pharyngitis (RR: 1.01; 95% CI: 0.87 to 1.18), otitis media (RR: 1.07; 95% CI: 0.83 to 1.37), and sinusitis (RR: 0.89; 95% CI: 0.76 to 1.05).
LIMITATIONS:
Lack of clearly defined criteria for respiratory infections and possible publication bias.
CONCLUSIONS: Regular use of ICS may not increase the risk of pneumonia or other respiratory infections in children with asthma.
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